Effective May
17, 2013, IBC's medical policy on artificial intervertebral disc
insertion will be updated to include artificial intervertebral disc insertion
in the cervical spine when medically necessary as an alternative surgical
treatment to preserve range of motion for a select population.
Previously, artificial intervertebral
disc insertion in the cervical spine was considered experimental and
investigational. However, based on the current available peer-reviewed
literature and clinical input, artificial intervertebral disc insertion in the
cervical spine will now be considered medically necessary in a select
population.
About artificial intervertebral
disc insertion
Artificial intervertebral disc
insertion is a technology intended for use in the cervical or lumbar spine to
treat degenerative disc disease (DDD). DDD is a common cause of neck and/or low
back pain. Spinal fusion is considered the established treatment for DDD for
the resolution of pain and neurologic symptoms. However, artificial
intervertebral disc insertion has been proposed as an alternative surgical
treatment.
The current evidence suggests that in a
select population, artificial intervertebral disc insertion in the cervical
spine may offer lower re-operation rates and preserve range of motion.
Additionally, mid-term results suggest that cervical artificial intervertebral
disc insertion is not inferior to spinal fusion.
The available peer-reviewed literature
and clinical input suggests that the current evidence for artificial
intervertebral disc insertion in the lumbar spine remains limited and
insufficient to permit conclusions regarding long-term safety and
effectiveness. Therefore, artificial intervertebral disc insertion in the
lumbar spine remains experimental and investigational.
Visit the Medical Policy Portal after May 17,
2013, to review the revised Medical Policy #11.14.19g: Artificial
Intervertebral Disc Insertion in its entirety.